Recurrent Peritoneal Malignant Mesothelioma
3 clinical trials · Condition
◉ Watch Recurrent Peritoneal Malignant Mesothelioma
| Record | Firm | Date |
|---|---|---|
| Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors (NCT03074513) | M.D. Anderson Cancer Center | 2017-03-03 |
| Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin (NCT02535312) | National Cancer Institute (NCI) | 2016-03-08 |
| Pembrolizumab in Treating Patients With Malignant Mesothelioma (NCT02399371) | University of Chicago | 2015-03-31 |
Track Recurrent Peritoneal Malignant Mesothelioma automatically
Every clearance here is in the API, with alerts when new ones post.